Dimension scores are derived from public data and fields; weighted into the composite. Reference only.
PHARM-SOFT GmbH is a German company that, according to its official website, has served the pharmacovigilance sector for over 20 years, primarily offering pharmacovigilance services and PV databases to pharmaceutical enterprises. Rather than being a purely general-purpose SaaS, it positions itself as a vertical enterprise software and outsourcing service provider combining "services + specialized databases."
Based on the scraped content, PHARM-SOFT covers a fairly complete pharmacovigilance chain: including data entry, drug safety support for clinical and non-interventional studies, medical assessment of adverse events, Medical Writing, literature retrieval and literature case processing, regulatory report generation, case creation, MedDRA coding, and Full Service pharmacovigilance outsourcing. In terms of reporting, it supports CIOMS, MedWatch, CIOMS II Line Listing, and mentions the ability to create and send E2B (XML) files. Its database products include saphëus and -iris-, but the official website does not elaborate on their specific interfaces, workflows, permission controls, or reporting capabilities.
The official website does not disclose pricing tiers, costs, free trials, or payment methods. The services emphasize a flexible "building block" approach to selecting and combining different modules, indicating that its business model likely relies on project-based, scope-based, or custom quoting. The deployment method is also unspecified, making it unclear whether it is a pure cloud SaaS, self-hosted, or a database managed/operated by PHARM-SOFT.
Its advantage lies in a clear focus on the vertical industry, understanding both pharmacovigilance business processes and providing database support; the service scope is relatively comprehensive, spanning from data entry to regulatory submission, making it suitable for pharma companies looking to outsource PV processes or supplement temporary capacity. The downside is that the website information is rather traditional, lacking details typically expected in modern SaaS procurement—such as third-party integrations, APIs, permission management, audit trails, data security certifications, and validation documents—along with a lack of pricing transparency.
It is better suited for pharmaceutical companies in the European or German markets requiring pharmacovigilance operational support, especially teams needing literature processing, individual case report creation, PSUR/DSUR/ASR writing, MedDRA coding, or E2B electronic submission support. If an enterprise is looking for a highly productized, global SaaS platform with self-service trials, they will need to further verify the product's capabilities directly with the vendor.
Access from mainland China cannot be determined from the website content, and payment methods are undisclosed. Chinese pharma companies with cross-border pharmacovigilance needs can consider it as a European PV outsourcing candidate; however, if they prioritize local implementation, Chinese language support, domestic regulatory compliance, and payment convenience, they should also evaluate domestic pharmacovigilance systems alongside international alternatives like Oracle Argus Safety, ArisGlobal, and Veeva Vault Safety.
⚠ This review is compiled from public sources and does not constitute a purchase recommendation. Verify all facts on the vendor's official site. Verify on pharmsoft.de official site.
pharmsoft.de is an Germany Legal & Tax provider. TG4G tracks its product information, an overall rating of 6.0/10, and a China-accessibility score of Limited (proxy recommended). Click "Visit Official Site" to reach pharmsoft.de directly.